D-068

Duloxetine-D₃ hydrochloride solution

100 μg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant^®

• Fórmula empírica (Notação de Hill): C₁₈D₃H₁₆NOS · HCl
• Peso molecular: 336.89
• Número CE: 200-659-6
• Número MDL: MFCD09752117
• Código UNSPSC: 41116107
• ID de substância PubChem: 329798627
• NACRES: NA.24

Propriedades

• grau: certified reference material
• Nível de qualidade: 300
• forma: liquid
• Características: Snap-N-Spike^®/Snap-N-Shoot^®
• embalagem: ampule of 1 mL
• fabricante/nome comercial: Cerilliant^®
• concentração: 100 μg/mL in methanol (as free base)
• técnica(s): gas chromatography (GC): suitable; liquid chromatography (LC): suitable
• aplicação(ões): clinical testing
• formato: single component solution
• temperatura de armazenamento: −20°C
• cadeia de caracteres SMILES: Cl.[2H]C([2H])([2H])NCC[C@H](Oc1cccc2ccccc12)c3cccs3
• InChI: 1S/C18H19NOS.ClH/c1-19-12-11-17(18-10-5-13-21-18)20-16-9-4-7-14-6-2-3-8-15(14)16;/h2-10,13,17,19H,11-12H2,1H3;1H/t17-;/m0./s1/i1D3;
• chave InChI: BFFSMCNJSOPUAY-HQKLNPQUSA-N

Descrição

Descrição geral

A stable-labeled internal standard suitable for numerous GC/MS and LC/MS applications from clinical toxicology and urine drug testing to forensic analysis and isotope dilution methods. Duloxetine, marketed in the US under the trade name Cymbalta^®, is a serotonin-norepinephrine reuptake inhibitor (SNRI) used to treat major depressive disorder and to alleviate pain associated with diabetic neuropathy, fibromyalgia, and osteoarthritis.

Aplicação

• Rapid Structure-Based Screening for COVID-19: Duloxetine-D₃ hydrochloride solution plays a key role in rapid structure-based screening, potentially informing the development of therapeutic agents for COVID-19 due to its properties as a serotonin-norepinephrine reuptake inhibitor, crucial for high-impact pharmaceutical research (Yang et al., 2020).


• UV-Triggered Drug Release: The high-purity Duloxetine-D₃ solution enhances UV-triggered drug release studies from mesoporous titanium nanoparticles loaded with pharmaceutical agents, indicating significant benefits for developing controlled drug delivery systems in biotechnological applications (Zuo et al., 2024).


• Antioxidant Activity and Eczema Treatment: Duloxetine-D₃ HCl serves as an internal standard in studies evaluating the antioxidant activities and therapeutic applications of drug-loaded liposomes for eczema treatment, highlighting its role in enhancing bioanalytical assay development (Shen et al., 2024).


• Synthesis and Application of EGFR Inhibitors for Cancer: As a stable isotope-labeled compound, Duloxetine-D₃ hydrochloride is used in the synthesis and clinical application studies of small-molecule EGFR inhibitors, underlining its critical application in cancer therapy research (Wang et al., 2024).


• Nanoparticle Drug Release Behaviors: The solution′s role in studying poly(lactic-co-glycolic acid) nanoparticles highlights its utility in pharmaceutical-grade calibration for analyzing hydrophilic and hydrophobic drug release behaviors, essential for pharmaceutical and biomedical research (Wang et al., 2024).

Informações legais

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

Cymbalta is a registered trademark of Eli Lilly and Co.

Snap-N-Shoot is a registered trademark of Cerilliant Corporation

Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

Informações de segurança

• Pictogramas: GHS02,GHS06,GHS08
• Palavra indicadora: Danger
• Frases de perigo: H225,H301 + H311 + H331,H370
• Declarações de precaução: P210 - P280 - P301 + P310 + P330 - P302 + P352 + P312 - P304 + P340 + P311
• Classificações de perigo: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
• Órgãos-alvo: Eyes
• Código de classe de armazenamento: 3 - Flammable liquids
• Classe de risco de água (WGK): WGK 1
• Ponto de fulgor (°F): 49.5 °F - closed cup
• Ponto de fulgor (°C): 9.7 °C - closed cup